Pharmacokinetics and drug dosing adjustments during continuous venovenous hemofiltration or hemodiafiltration in critically ill patients.
about
Meropenem dosing in critically ill patients with sepsis receiving high-volume continuous venovenous hemofiltrationTreatment with echinocandins during continuous renal replacement therapyAntimicrobial Doses in Continuous Renal Replacement Therapy: A Comparison of Dosing Strategies.Effectiveness of pharmacist dosing adjustment for critically ill patients receiving continuous renal replacement therapy: a comparative study.Appropriate antibiotic dosing in severe sepsis and acute renal failure: factors to consider.Dosing of antimicrobial agents in critically-ill patients with acute kindey injury and continuous venvenous haemofiltration.Antimicrobial dosing concepts and recommendations for critically ill adult patients receiving continuous renal replacement therapy or intermittent hemodialysis.Continuous-infusion beta-lactam antibiotics during continuous venovenous hemofiltration for the treatment of resistant gram-negative bacteria.Pharmacokinetics of ganciclovir during continuous venovenous hemodiafiltration in critically ill patients.How to optimize drug delivery in renal replacement therapy.Understanding renal replacement therapy and dosing of drugs in pediatric patients with kidney disease.A stepwise approach for the management of poisoning with extracorporeal treatments.Antiepileptic Drug Removal by Continuous Renal Replacement Therapy: A Review of the Literature.Influence of continuous venovenous hemofiltration and continuous venovenous hemodiafiltration on the disposition of doripenem.Peramivir pharmacokinetics in two critically ill adults with 2009 H1N1 influenza A concurrently receiving continuous renal replacement therapy.Trimethoprim/Sulfamethoxazole pharmacokinetics in two patients undergoing continuous venovenous hemodiafiltration.Impact of pharmacist antimicrobial dosing adjustments in septic patients on continuous renal replacement therapy in an intensive care unit.The adsorption of vancomycin by polyacrylonitrile, polyamide, and polysulfone hemofilters.Pentobarbital Removal During Continuous Venovenous Hemofiltration: Case Report and Review of the Literature.Antibiotic dosing in critically ill patients receiving CRRT: underdosing is overprevalent.Factors affecting serum concentration of vancomycin in critically ill oliguric pediatric patients receiving continuous venovenous hemodiafiltration.Pharmacokinetics-pharmacodynamics issues relevant for the clinical use of beta-lactam antibiotics in critically ill patients
P2860
Q24620193-F68BB66D-78BC-42D9-9D20-D2288FCAD5FDQ27012864-59B14577-304E-4DC2-931D-E02E4AA99594Q27313917-56851418-60E8-407B-B228-613D2066E894Q33734676-BBCE440F-6DAE-494C-A241-B7A158833349Q36070363-2D566677-97EB-424F-8998-7A84D8536BB0Q37088305-F7C46978-6B5A-4F00-B578-3D5F77A1BB9EQ37461431-FD72F8DC-448F-43F6-BF14-DD9D6DE7425DQ37543906-E73B0D7A-3027-4B87-A6E3-B4916AD1E61CQ37544453-88CEDBB5-BB00-49C9-8507-FD558F3A400BQ37868687-7FABE2C1-D4BA-465B-9A00-79162244A7F0Q37974645-F7575236-B59A-4658-A889-DD0B82DFAF33Q38201803-C9600FF9-6233-4044-B17C-93F08C79E003Q38944443-A3CE4189-3B05-4C70-8B27-ED0ECDF40157Q42706267-90A6524A-7FC5-474B-8EB1-017C0E4BD25DQ42875451-A05405B1-A3A4-41A1-81DD-BDC603EE3706Q42914760-B8D900D8-C785-49D9-A9A4-E0330953EF0FQ45812223-B8B7CE68-BA1B-4A13-A0C8-B2330DBF1BC9Q46817846-3096C224-0905-4288-BE38-01A25E2FEDE8Q47957740-A0E983F9-717D-4A37-87AF-7A3AB80387BBQ51040518-0023FE07-1AB9-4D52-BA0C-36C479FEBDF0Q55463665-C24BC145-5F83-42E1-9389-DCA851D932BDQ58701649-7EC5F7C1-A756-40AE-90CA-B6B80563A412
P2860
Pharmacokinetics and drug dosing adjustments during continuous venovenous hemofiltration or hemodiafiltration in critically ill patients.
description
2001 nî lūn-bûn
@nan
2001 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Pharmacokinetics and drug dosi ...... on in critically ill patients.
@ast
Pharmacokinetics and drug dosi ...... on in critically ill patients.
@en
Pharmacokinetics and drug dosi ...... on in critically ill patients.
@nl
type
label
Pharmacokinetics and drug dosi ...... on in critically ill patients.
@ast
Pharmacokinetics and drug dosi ...... on in critically ill patients.
@en
Pharmacokinetics and drug dosi ...... on in critically ill patients.
@nl
prefLabel
Pharmacokinetics and drug dosi ...... on in critically ill patients.
@ast
Pharmacokinetics and drug dosi ...... on in critically ill patients.
@en
Pharmacokinetics and drug dosi ...... on in critically ill patients.
@nl
P2860
P1476
Pharmacokinetics and drug dosi ...... on in critically ill patients.
@en
P2093
P2860
P304
P356
10.1034/J.1399-6576.2001.450802.X
P407
P577
2001-09-01T00:00:00Z